service_image

Rashmi Pant’s presentation topic: Impact of withdrawal/down scaling of MNC Pharma operations in India on Indian Pharmaceutical Companies


service_image

Rashmi Pant delivered Oral Presentation on Artificial Intelligence in Drug Discovery- A focus on Clinical Research Companies – 3rd March 2022 at the International Conference on Drug Discovery and Development held during March 03, 2022 as a Webinar


service_image

Conference Theme: International Conference (Virtual Mode) on Advances in theory, Research & Practices in Management (GLSU-ATRPM) 2021- 1 May 2021 Conference Paper: Emerging Trends in Global Pharmaceutical Industry Start-ups The paper shows the Emergence of Pharmaceutical Industry Start-ups providing artificial intelligence and related technology services as a single entity or in collaboration. Humongous utilization of …


service_image

Conference details -Two-day online conference -27 & 28 Feb 2021 organized by Bodhi International Journal & B.K school of Professional & Management studies, Gujarat University. Conference theme – Bodhi Conference on Emerging trends in Economics, Commerce & Management. Conference Paper :  Emerging Trends in skill set requirements for jobs in Digital Content Production Jobs related …


DOMM has organized an expert lecture on 2nd January, 2021. The speaker, Ms. Rashmi Pant, is a leader in the market research consulting space. With over 22 years of experience and associations with Torrent Pharma, Intas Pharma, Sun Pharma Advanced Research Company, Veeda Clinical Research, and Cliantha Research, she has accumulated deep marketing intelligence based …



Rashmi Pant Participated in Pharmaconfex 2020

Market Research Conferences

service_image

Rashmi Participated in Pharmaconfex 2020 6th National conference on Pharma & Allied Sectors. Her session was focused on Basic Controls during Covid-19 in Pharma Industry


service_image

The Indian Clinical Trial market is currently going through challenging times. However Clinical Trial market ‘s major Growth Driver s are the patient trials on Off patent generic drugs i.e BA BE Studies. As far the sites for BA BE studies for Off patent drugs are concerned, the clinical trial sites for the same are reaching de growth …